Biocryst Pharmaceuticals Inc. 13F holders
319 funds reported a position in Biocryst Pharmaceuticals Inc. in their 13F for the quarter ended 30 June 2026, together 263.8 million shares worth $2.64 billion. Against the quarter before, 51 opened a position, 130 added, 86 trimmed and 38 sold out; together they bought a net 11.6 million shares. The largest holders: BlackRock, Inc., Ra Capital Management, L.P. and State Street Corp.
Funds holding319+16 on Q1 2026
Shares they held263.8Mworth $2.64 billion
Net bought on the quarter11.6M sharesabout $116.3 million at the funds' values
Funds buying to selling181 to 124opened or added, to cut or sold
Opened 51Added 130Held 49Trimmed 86Sold out 38
What each fund did in BCRX against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in BCRX in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 37 reported a position in Biocryst Pharmaceuticals Inc.: 2 opened one, 12 added, 12 trimmed and 10 sold out, a net 54,600 shares sold.
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 8 reported a position in Biocryst Pharmaceuticals Inc. in a 13F for the quarter ended 30 June 2026. The largest: Two Sigma Investments, 6.8 million shares worth $67.8 million, 0.1% of its reported book. New this quarter: Point72 Asset Management. In the quarter, 7 funds added or opened a position and 1 trimmed or sold out; together they bought a net 6.8 million shares, about $68.4 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| Two Sigma Investments | 6,775,349 | $67.8 million | 0.1% | +382,721 | added | 30 June 2026 | 13F |
| Geode Capital Management | 6,248,046 | $62.5 million | 0.0% | +465,270 | added | 30 June 2026 | 13F |
| Millennium Management | 3,394,729 | $33.9 million | 0.0% | +3,207,008 | added | 30 June 2026 | 13F |
| Renaissance Technologies | 2,530,290 | $25.3 million | 0.0% | +1,753,300 | added | 30 June 2026 | 13F |
| Citadel Advisors | 1,759,160 | $17.6 million | 0.0% | +740,417 | added | 30 June 2026 | 13F |
| FMR LLC | 808,903 | $8.1 million | 0.0% | +175,771 | added | 30 June 2026 | 13F |
| Bridgewater Associates | 491,057 | $4.9 million | 0.0% | -146,997 | trimmed | 30 June 2026 | 13F |
| Point72 Asset Management | 260,917 | $2.6 million | 0.0% | +260,917 | new | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 23,893,036 | 9.06% | $238.9 million | 0.00% | +1,242,048 | 13F |
| Ra Capital Management, L.P. | 15,827,186 | 6.00% | $158.3 million | 1.38% | no change | 13F |
| State Street Corp. | 15,191,098 | 5.76% | $151.9 million | 0.00% | +2,982,738 | 13F |
| Deerfield Management Company, L.P. | 15,096,403 | 5.72% | $151.0 million | 1.88% | +58,403 | 13F |
| Vanguard Capital Management LLC | 11,364,236 | 4.31% | $113.6 million | 0.00% | +228,474 | 13F |
| Vanguard Portfolio Management LLC | 11,139,158 | 4.22% | $111.4 million | 0.01% | -105,467 | 13F |
| TCG Crossover Management, LLC | 11,020,968 | 4.18% | $110.2 million | 2.65% | no change | 13F |
| Perceptive Advisors LLC | 10,308,888 | 3.91% | $103.1 million | 1.60% | +2,874,855 | 13F |
| Jupiter Topco LLC | 9,540,764 | 3.62% | $95.3 million | 0.04% | first 13F | 13F |
| Vestal Point Capital, LP | 8,300,000 | 3.15% | $83.0 million | 1.94% | +1,275,000 | 13F |
| Two Sigma Investments, LP | 6,775,349 | 2.57% | $67.8 million | 0.05% | +382,721 | 13F |
| Geode Capital Management, LLC | 6,248,046 | 2.37% | $62.5 million | 0.00% | +465,270 | 13F |
| Aberdeen Group plc | 5,310,871 | 2.01% | $53.1 million | 0.07% | +270,201 | 13F |
| UBS Group AG | 5,078,280 | 1.92% | $50.8 million | 0.01% | +134,286 | 13F |
| Bank of America Corp. | 4,801,284 | 1.82% | $48.0 million | 0.00% | -290,481 | 13F |
| Goldman Sachs Group Inc. | 4,481,874 | 1.70% | $44.8 million | 0.01% | +2,134,431 | 13F |
| Frazier Life Sciences Management, L.P. | 4,009,240 | 1.52% | $40.1 million | 0.87% | no change | 13F |
| Nuveen, LLC | 4,007,237 | 1.52% | $40.1 million | 0.01% | +187,974 | 13F |
| Nantahala Capital Management, LLC | 3,802,320 | 1.44% | $38.0 million | 1.16% | 13F | |
| Millennium Management LLC | 3,394,729 | 1.29% | $33.9 million | 0.02% | +3,207,008 | 13F |
| GW&K Investment Management, LLC | 3,171,113 | 1.20% | $31.7 million | 0.25% | -69,349 | 13F |
| Jane Street Group, LLC | 2,762,683 | 1.05% | $27.6 million | 0.02% | +2,140,076 | 13F |
| Dimensional Fund Advisors LP | 2,718,781 | 1.03% | $27.2 million | 0.01% | +28,130 | 13F |
| Fisher Asset Management, LLC | 2,604,027 | 0.99% | $26.0 million | 0.01% | -129,226 | 13F |
| Renaissance Technologies LLC | 2,530,290 | 0.96% | $25.3 million | 0.04% | +1,753,300 | 13F |
| Kynam Capital Management, LP | 2,522,660 | 0.96% | $25.2 million | 1.39% | -3,158,135 | 13F |
| Candriam S.C.A. | 2,514,949 | 0.95% | $25.1 million | 0.11% | +228,108 | 13F |
| Charles Schwab Investment Management Inc. | 2,353,291 | 0.89% | $23.5 million | 0.00% | +2,886 | 13F |
| Rice Hall James & Associates, LLC | 2,332,043 | 0.88% | $23.3 million | 1.14% | +101,938 | 13F |
| Northern Trust Corp. | 2,255,731 | 0.85% | $22.6 million | 0.00% | +151,006 | 13F |
| AQR Capital Management LLC | 2,214,302 | 0.84% | $22.1 million | 0.01% | +1,774,161 | 13F |
| Morgan Stanley | 1,999,684 | 0.76% | $20.0 million | 0.00% | -23,304 | 13F |
| Eversept Partners, LP | 1,865,653 | 0.71% | $18.7 million | 1.02% | -1,174,167 | 13F |
| Orbimed Advisors LLC | 1,852,000 | 0.70% | $18.5 million | 0.35% | +426,800 | 13F |
| Healthcare of Ontario Pension Plan Trust Fund | 1,844,912 | 0.70% | $18.4 million | 0.03% | +617,872 | 13F |
| Stifel Financial Corp. | 1,826,234 | 0.69% | $18.3 million | 0.01% | +1,050 | 13F |
| Vanguard Fiduciary Trust Co. | 1,759,573 | 0.67% | $17.6 million | 0.00% | +95,276 | 13F |
| Citadel Advisors LLC | 1,759,160 | 0.67% | $17.6 million | 0.01% | +740,417 | 13F |
| Jupiter Asset Management Ltd | 1,642,874 | 0.62% | $16.4 million | 0.08% | +446,503 | 13F |
| IMC-Chicago, LLC | 1,634,336 | 0.62% | $16.3 million | 0.15% | +1,003,046 | 13F |
| Parkman Healthcare Partners LLC | 1,624,279 | 0.62% | $16.2 million | 1.67% | -83,820 | 13F |
| Legal & General Group Plc | 1,455,514 | 0.55% | $14.6 million | 0.00% | +44,315 | 13F |
| OP Asset Management Ltd | 1,340,990 | 0.51% | $13.4 million | 0.14% | +88,127 | 13F |
| Invesco Ltd. | 1,233,783 | 0.47% | $12.3 million | 0.00% | -75,030 | 13F |
| Susquehanna International Group, LLP | 1,195,651 | 0.45% | $12.0 million | 0.01% | -1,619,653 | 13F |
| Pictet Asset Management Holding SA | 1,249,771 | 0.47% | $12.0 million | 0.01% | +778,198 | 13F |
| BNP Paribas Financial Markets | 1,174,052 | 0.44% | $11.7 million | 0.01% | -128,205 | 13F |
| First Trust Advisors LP | 1,120,469 | 0.42% | $11.2 million | 0.01% | +319,569 | 13F |
| HRT Financial LP | 1,081,523 | 0.41% | $10.8 million | 0.02% | new | 13F |
| Moore Capital Management, LP | 848,336 | 0.32% | $8.5 million | 0.20% | new | 13F |
The 50 largest of the 319 funds that reported a position in BCRX in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Options the funds reported on BCRX
| Fund | Option | Shares under the options | Value of those shares | Quarter ended | Filing |
|---|---|---|---|---|---|
| Citadel Advisors | Calls | 232,200 | $2.3 million | 30 June 2026 | 13F |
| Citadel Advisors | Puts | 145,000 | $1.4 million | 30 June 2026 | 13F |
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read more
They are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 14 August 2026 | 13G/A | RA Capital Management, L.P. and 7 others | 15.8 million | 6.2% | 30 June 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 7 August 2026 | 13G | State Street Corporation and 1 other | 15.2 million | 6.0% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 12 May 2026 | 13G | State Street Corporation and 1 other | 12.2 million | 4.9% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 29 April 2026 | 13G | Vanguard Capital Management and 1 other | 13.0 million | 5.2% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 26 March 2026 | 13G/A | The Vanguard Group and 1 other | 0 | 0.0% | 13 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 12 February 2026 | 13G/A | Deerfield Mgmt, L.P. and 7 others | 14.3 million | 6.8% | 31 December 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 9 February 2026 | 13G | State Street Corporation and 1 other | 11.1 million | 5.3% | 31 December 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 12 November 2025 | 13G | RA Capital Management, L.P. and 7 others | 15.3 million | 7.3% | 4 November 2025 | passive, under 20% (13d-1(c)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 21 September 2026 | 328 | $8.68 | SEC |
| 15 September 2026 | 50,200 | $8.23 | SEC |
| 10 September 2026 | 1,475 | $8.81 | SEC |
| 2 September 2026 | 6,264 | $9.92 | SEC |
| 31 August 2026 | 10,200 | $9.82 | SEC |
| 24 August 2026 | 1,309 | $9.55 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.